Technology News and Research

RSS

Tobacco-free cigarettes may be more carcinogenic than tobacco products: Study

Using the same technique they developed to document the harmful effects of tobacco products, a team of researchers found that cigarettes made without tobacco or nicotine may be more carcinogenic because they actually induce more extensive DNA damage than tobacco products.

13 May 2010

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

St. Jude Medical, Inc., a global medical device company, today announced it will display a number of new products and clinical solutions from the company's Cardiac Rhythm Management and Atrial Fibrillation Divisions at Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.

13 May 2010

Proposed cuts in Medicare payments impact access to healthcare: Poll

An independent poll recently conducted on behalf of the American Osteopathic Association (AOA) shows that an alarming number of physicians will stop seeing Medicare beneficiaries if current payment policies are not reformed.

13 May 2010

Regeneron Pharmaceuticals provides update on REGN727, REGN475 antibody product candidates

Regeneron Pharmaceuticals, Inc. (REGN) provided an update on two antibody product candidates in its pipeline and scheduled its first Investor Day to be held in New York City on July 15, 2010. Both product candidates, REGN727 (SAR236553) and, REGN475 (SAR164877) are being developed with sanofi-aventis under a global, strategic collaboration to discover, develop, and commercialize fully human antibodies.

13 May 2010

PositiveID files provisional patent covering glucose level RF sensing technology

PositiveID Corporation announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office covering the interface between a radio frequency ("RF") powered resonant electromechanical drive and the fluids in the interstitial space of a patient for continuous detection of glucose levels in a patient. The interface employs a resonant electromechanical drive for mass sensing and RF communication of glucose levels.

13 May 2010

FDA should apply equal rigor in assessing food claims and drug approvals, says new report

The U.S. Food and Drug Administration should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says a new report from the Institute of Medicine.

13 May 2010

Computerized systems can detect early eye problems related to diabetes: UI team

People with diabetes have an increased risk of blindness, yet nearly half of the approximately 23 million Americans with diabetes do not get an annual eye exam to detect possible problems.

13 May 2010

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

13 May 2010

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac resynchronization therapy defibrillator (CRT-D) and Fortify™ implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power.

13 May 2010

pSivida reports consolidated net loss of $2.7 million for third-quarter 2010

pSivida Corp., a drug delivery company with two of the only three ophthalmic sustained release delivery products approved by the FDA for treatment of back-of-the-eye diseases, today announced financial results for its third quarter and nine months ended March 31, 2010.

13 May 2010

Researchers develop new technology to manage prostate cancer treatment

Researchers at Queen's University have developed a new way of performing lab tests that could improve the way doctors manage prostate cancer treatment. It will allow them to identify with unprecedented accuracy losses of a gene called PTEN that is associated with an aggressive group of prostate cancers.

13 May 2010

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System, Boston Scientific's third-generation drug-eluting stent (DES) technology.

13 May 2010

Study evaluates cost-utility of MARS treatment in ALF patients

Numerous studies have documented the favorable effects of MARS albumin dialysis treatment on clinical and laboratory parameters and survival in liver failure patients. However, to ensure that limited resources are utilized in an ethical manner, the subjective feelings of the patient in terms of health-related quality of life and costs should also be taken into account.

13 May 2010

FDA approves Evia pacemaker for distribution in the U.S.

BIOTRONIK today announced that the U.S. Food and Drug Administration has cleared the Evia pacemaker for distribution in the U.S., giving physicians and patients access to a unique Bradycardia system designed and manufactured with BIOTRONIK's unparalleled legacy of quality.

13 May 2010

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Carrot Medical, a leading designer of integrated medical imaging display systems, and MAVIG GmbH, the leading manufacturer of medical imaging monitor suspension systems, announced today the execution of a global marketing and sales channel partnership agreement. This partnership provides a semi-exclusive contract for the sale of all products through MAVIG's global sales channel while offering MAVIG access to the next generation of integrated medical imaging display technology.

12 May 2010

NIH awards PLx Pharma multiple grants for development of GI safer NSAIDs

PLx Pharma, a pharmaceutical company developing safer formulations of proven non-steroidal anti-inflammatory drugs (NSAIDs), today announced that it has been awarded multiple grants from the National Institutes of Health (NIH) totaling approximately $2,000,000. This funding has been awarded to support further advancement of a range of products currently under development by PLx.

12 May 2010

Brandeis University surveys assess how recent legislation affects consumer access to behavioral health services

Brandeis University is launching two surveys of the nation's private health plans to assess how recent legislation affects quality of and consumer access to behavioral health services. Both the federal parity law and national health reform are likely to affect behavioral health care

12 May 2010

RevMed partners with Santa Monica to set up safety syringe manufacturing facility in Brazil

Revolutions Medical Corporation, has signed an agreement of understanding for the setting up of a manufacturing facility in Brazil to produce the RevVac safety syringe for domestic and global markets and to facilitate distribution throughout South America.

12 May 2010

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Spectranetics Corporation today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.

12 May 2010

DATATRAK International's first-quarter 2010 revenue decreased to $1,678,000

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the first quarter of 2010: $1.7 million revenue, $10.7 million backlog and 82% gross profit margin; all resulting in profitability.

12 May 2010

Technology News and Research

Tobacco-free cigarettes may be more carcinogenic than tobacco products: Study

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

Proposed cuts in Medicare payments impact access to healthcare: Poll

Regeneron Pharmaceuticals provides update on REGN727, REGN475 antibody product candidates

PositiveID files provisional patent covering glucose level RF sensing technology

FDA should apply equal rigor in assessing food claims and drug approvals, says new report

Computerized systems can detect early eye problems related to diabetes: UI team

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

pSivida reports consolidated net loss of $2.7 million for third-quarter 2010

Researchers develop new technology to manage prostate cancer treatment

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Study evaluates cost-utility of MARS treatment in ALF patients

FDA approves Evia pacemaker for distribution in the U.S.

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

NIH awards PLx Pharma multiple grants for development of GI safer NSAIDs

Brandeis University surveys assess how recent legislation affects consumer access to behavioral health services

RevMed partners with Santa Monica to set up safety syringe manufacturing facility in Brazil

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

DATATRAK International's first-quarter 2010 revenue decreased to $1,678,000

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News